According to Sky News, NHS officials announced that hundreds of people in England with rare eye cancer will soon have access ...

Tebentafusp is the first treatment of its kind for uveal melanoma, which develops from cells in the middle layer of the eye, ...

The median launch prices in the US increased from $29,630 (IQR, $1322-$49,691) for drugs approved in 201 to $84,240 (IQR, ...

The first ever drug for an aggressive form of eye cancer is being fast-tracked to hundreds of patients by the NHS across England. One patient receiving the treatment described the rollout as “the best ...

Bharath Advanced Therapeutics (BAT), as a key organiser of Cancer NEXT 2024 alongside Nizam's Institute of Medical Sciences (NIMS) and Federation of Asian Biotech Associations (FABA), successfully led ...

BriaCell Therapeutics (BCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily ...

A cancer therapy that prompts the body's immune defenses against viruses and bacteria to attack tumors can make patients more ...

Study uses spatial transcriptomics to map intratumoral heterogeneity and microenvironmental dynamics in triple-negative ...

Shares of Janux Therapeutics surged after its prostate cancer treatment was selected for expansion trials following what it called encouraging efficacy and safety results.

Novocure stock catapulted early Monday after the company's cancer-treating device succeeded in a study of patients with pancreatic cancer.

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...

Discover how principles from agricultural pest resistance management can offer solutions for combating cancer treatment ...